Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 521

1.

ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.

Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Noordegraaf AV, Peacock AJ.

Eur Respir J. 2018 Dec 21. pii: 1800332. doi: 10.1183/13993003.00332-2018. [Epub ahead of print]

PMID:
30578391
2.

Successful treatment of solar urticaria with UVA1 hardening in three patients.

Lyons AB, Peacock A, Zubair R, Hamzavi IH, Lim HW.

Photodermatol Photoimmunol Photomed. 2018 Dec 21. doi: 10.1111/phpp.12447. [Epub ahead of print]

PMID:
30576021
3.

Pulmonary hypertension in chronic lung disease and hypoxia.

Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W.

Eur Respir J. 2018 Dec 13. pii: 1801914. doi: 10.1183/13993003.01914-2018. [Epub ahead of print]

4.

Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.

Vachiéry JL, Galiè N, Barberá JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Blair C, Miller KL, Langley J, Rubin LJ; AMBITION Study Group.

J Heart Lung Transplant. 2018 Nov 22. pii: S1053-2498(18)31742-X. doi: 10.1016/j.healun.2018.11.006. [Epub ahead of print]

5.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, Ross RVM, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Noordegraaf AV, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2018 Dec 5. pii: S2213-2600(18)30409-0. doi: 10.1016/S2213-2600(18)30409-0. [Epub ahead of print]

6.

What do we know about alcohol mixed with energy drink (AmED) use in Australia? Expanding local evidence.

Pennay A, Peacock A, Droste N, Miller P, Bruno R, Wadds P, Tomsen S, Lubman D.

Public Health Res Pract. 2018 Sep 27;28(3). pii: 2831817. doi: 10.17061/phrp2831817.

7.

Patient-reported outcomes in hidradenitis suppurativa: a review.

Vellaichamy G, Braunberger TL, Jones JL, Peacock A, Nahhas AF, Hamzavi IH.

G Ital Dermatol Venereol. 2018 Oct 29. doi: 10.23736/S0392-0488.18.06021-2. [Epub ahead of print]

PMID:
30375207
8.

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR, Baras A, Sampson KJ, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Church C, Coghlan G, Corris PA, Eyries M, Gibbs JSR, Girerd B, Houweling AC, Humbert M, Guignabert C, Kiely DG, Lawrie A, MacKenzie Ross RV, Martin JM, Montani D, Peacock AJ, Pepke-Zaba J, Soubrier F, Suntharalingam J, Toshner M, Treacy CM, Trembath RC, Vonk Noordegraaf A, Wharton J, Wilkins MR, Wort SJ, Yates K, Gräf S, Morrell NW, Krishnan U, Rosenzweig EB, Shen Y, Nichols CG, Kass RS, Chung WK.

Circ Genom Precis Med. 2018 Oct;11(10):e002087. doi: 10.1161/CIRCGEN.118.002087.

PMID:
30354297
9.

Structural Determinants of the Stability of Enzyme-Responsive Polyion Complex Nanoparticles Targeting Pseudomonas aeruginosa's Elastase.

Insua I, Petit M, Blackman LD, Keogh R, Pitto-Barry A, O'Reilly RK, Peacock AFA, Krachler AM, Fernandez-Trillo F.

ChemNanoMat. 2018 Aug;4(8):807-814. doi: 10.1002/cnma.201800054. Epub 2018 Apr 23.

10.

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs.

Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman M, Vickerman P, Blach S, Cunningham EB, Dumchev K, Lynskey M, Stone J, Trickey A, Razavi H, Mattick RP, Farrell M, Dore GJ, Degenhardt L.

Addiction. 2019 Jan;114(1):150-166. doi: 10.1111/add.14393. Epub 2018 Aug 28.

PMID:
30035835
11.

pH dependent binding in de novo hetero bimetallic coiled coils.

Teare P, Smith CF, Adams SJ, Anbu S, Ciani B, Jeuken LJC, Peacock AFA.

Dalton Trans. 2018 Aug 21;47(31):10784-10790. doi: 10.1039/c8dt01568f. Epub 2018 Jul 19.

12.

Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?

Hickman M, Larney S, Peacock A, Jones H, Grebely J, Degenhardt L.

Addiction. 2018 Oct;113(10):1768-1774. doi: 10.1111/add.14383. Epub 2018 Aug 9. No abstract available.

PMID:
29989282
13.

Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting.

Peacock A, Larance B, Bruno R, Pearson SA, Buckley NA, Farrell M, Degenhardt L.

Addiction. 2018 Jul 10. doi: 10.1111/add.14380. [Epub ahead of print]

PMID:
29989247
14.

Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England.

Martinez C, Wallenhorst C, Teal S, Cohen AT, Peacock AJ.

Pulm Circ. 2018 Jul-Sep;8(3):2045894018791358. doi: 10.1177/2045894018791358. Epub 2018 Jul 9.

15.

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.

Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L.

Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.

16.

The Right Heart-Pulmonary Circulation Unit: Physiopathology.

Naeije R, Vanderpool R, Peacock A, Badagliacca R.

Heart Fail Clin. 2018 Jul;14(3):237-245. doi: 10.1016/j.hfc.2018.02.001. Review.

PMID:
29966623
17.

Optical-resonance-enhanced nonlinearities in a MoS2-coated single-mode fiber.

Zhang H, Healy N, Runge AFJ, Huang CC, Hewak DW, Peacock AC.

Opt Lett. 2018 Jul 1;43(13):3100-3103. doi: 10.1364/OL.43.003100.

PMID:
29957791
18.

Pulmonary hypertension and pulmonary vascular disease: course report.

Peacock A, Owuor A.

Breathe (Sheff). 2018 Mar;14(1):e4-e5. doi: 10.1183/20734735.019917.

19.

Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension.

Brash L, Barnes GD, Brewis MJ, Church AC, Gibbs SJ, Howard LSGE, Jayasekera G, Johnson MK, McGlinchey N, Onorato J, Simpson J, Stirrat C, Thomson S, Watson G, Wilkins MR, Xu C, Welsh DJ, Newby DE, Peacock AJ.

JACC Basic Transl Sci. 2018 Mar 28;3(2):176-186. doi: 10.1016/j.jacbts.2018.01.013. eCollection 2018 Apr.

20.

A Framework Facilitates Development of a Mobile App.

Choi J, Baker E, Nalawade S, Peacock A, Lee H, Choi WJ.

Stud Health Technol Inform. 2018;250:97-100.

PMID:
29857397
21.

Alcohol use disorder and associated physical health complications and treatment amongst individuals with and without opioid dependence: A case-control study.

Pikovsky M, Peacock A, Larney S, Larance B, Conroy E, Nelson E, Degenhardt L.

Drug Alcohol Depend. 2018 Jul 1;188:304-310. doi: 10.1016/j.drugalcdep.2018.04.016. Epub 2018 May 21.

PMID:
29807218
22.

Typology of new psychoactive substance use among the general Australian population.

Sutherland R, Peacock A, Roxburgh A, Barratt MJ, Burns L, Bruno R.

Drug Alcohol Depend. 2018 Jul 1;188:126-134. doi: 10.1016/j.drugalcdep.2018.03.034. Epub 2018 May 3.

PMID:
29775956
23.

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report.

Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, Giovino GA, West R, Hall W, Griffiths P, Ali R, Gowing L, Marsden J, Ferrari AJ, Grebely J, Farrell M, Degenhardt L.

Addiction. 2018 Oct;113(10):1905-1926. doi: 10.1111/add.14234. Epub 2018 Jun 4. Review.

PMID:
29749059
24.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

25.

Effectiveness of inpatient withdrawal and residential rehabilitation interventions for alcohol use disorder: A national observational, cohort study in England.

Eastwood B, Peacock A, Millar T, Jones A, Knight J, Horgan P, Lowden T, Willey P, Marsden J.

J Subst Abuse Treat. 2018 May;88:1-8. doi: 10.1016/j.jsat.2018.02.001. Epub 2018 Feb 7.

PMID:
29606222
26.

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.

Peacock A, Larance B, Farrell M, Cairns R, Buckley N, Degenhardt L.

BMJ Open. 2018 Mar 23;8(3):e020006. doi: 10.1136/bmjopen-2017-020006.

27.

Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: A national observational cohort study in England.

Peacock A, Eastwood B, Jones A, Millar T, Horgan P, Knight J, Randhawa K, White M, Marsden J.

Drug Alcohol Depend. 2018 May 1;186:60-67. doi: 10.1016/j.drugalcdep.2018.01.019. Epub 2018 Mar 13.

PMID:
29550623
28.

Energy drinks, alcohol and cardiovascular functioning.

Forward J, Akhurst J, Bruno R, Peacock A.

Drug Alcohol Depend. 2018 Apr 1;185:423-424. doi: 10.1016/j.drugalcdep.2018.02.006. Epub 2018 Mar 3. No abstract available.

PMID:
29526440
29.

Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort Study.

Peacock A, Hutchinson D, Wilson J, McCormack C, Bruno R, Olsson CA, Allsop S, Elliott E, Burns L, Mattick RP.

Nutrients. 2018 Mar 7;10(3). pii: E319. doi: 10.3390/nu10030319.

30.

The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing.

Degenhardt L, Glantz M, Bharat C, Peacock A, Lago L, Sampson N, Kessler RC.

Drug Alcohol Rev. 2018 May;37(4):546-556. doi: 10.1111/dar.12679. Epub 2018 Mar 5.

PMID:
29505682
31.

Social deprivation and prognosis in Scottish patients with pulmonary arterial hypertension.

Pellino K, Kerridge S, Church C, Peacock AJ, Crowe T, Jayasekera G, Johnson MK, MacKenzie AM.

Eur Respir J. 2018 Jan 31;51(2). pii: 1700444. doi: 10.1183/13993003.00444-2017. Print 2018 Feb.

PMID:
29386345
32.

The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.

Larance B, Dobbins T, Peacock A, Ali R, Bruno R, Lintzeris N, Farrell M, Degenhardt L.

Lancet Psychiatry. 2018 Feb;5(2):155-166. doi: 10.1016/S2215-0366(18)30003-8. Epub 2018 Jan 11.

PMID:
29336948
33.

Guilt-proneness is associated with the use of protective behavioral strategies during episodes of alcohol use.

Treeby MS, Rice SM, Cocker F, Peacock A, Bruno R.

Addict Behav. 2018 Apr;79:120-123. doi: 10.1016/j.addbeh.2017.12.027. Epub 2017 Dec 22.

PMID:
29288985
34.

Highly nonlinear yttrium-aluminosilicate optical fiber with a high intrinsic stimulated Brillouin scattering threshold.

Tuggle M, Kucera C, Hawkins T, Sligh D, Runge AFJ, Peacock AC, Dragic P, Ballato J.

Opt Lett. 2017 Dec 1;42(23):4849-4852. doi: 10.1364/OL.42.004849.

PMID:
29216126
35.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

PMID:
29167297
36.

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.

Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, Grebely J, Dumchev KV, Griffiths P, Hines L, Cunningham EB, Mattick RP, Lynskey M, Marsden J, Strang J, Degenhardt L.

Lancet Glob Health. 2017 Dec;5(12):e1208-e1220. doi: 10.1016/S2214-109X(17)30373-X. Epub 2017 Oct 23. Review.

37.

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, Lynskey M, Griffiths P, Mattick RP, Hickman M, Larney S.

Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23. Review. Erratum in: Lancet Glob Health. 2017 Nov 15;:.

38.

Non-invasive imaging of global and regional cardiac function in pulmonary hypertension.

Crowe T, Jayasekera G, Peacock AJ.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217742000. doi: 10.1177/2045893217742000. Epub 2017 Oct 24.

39.

Tapered silicon core fibers with nano-spikes for optical coupling via spliced silica fibers.

Ren H, Aktas O, Franz Y, Runge AFJ, Hawkins T, Ballato J, Gibson UJ, Peacock AC.

Opt Express. 2017 Oct 2;25(20):24157-24163. doi: 10.1364/OE.25.024157.

PMID:
29041361
40.

A novel single-beat approach to assess right ventricular systolic function.

Bellofiore A, Vanderpool R, Brewis MJ, Peacock AJ, Chesler NC.

J Appl Physiol (1985). 2018 Feb 1;124(2):283-290. doi: 10.1152/japplphysiol.00258.2017. Epub 2017 Oct 12.

PMID:
29025899
41.

Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses.

Larance B, Degenhardt L, Peacock A, Gisev N, Mattick R, Colledge S, Campbell G.

Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S203-S205. doi: 10.1111/dar.12617. Epub 2017 Oct 12.

PMID:
29024092
42.

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzie Ross R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P, Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, Vonk Noordegraaf A, Wilkins MR, Wort SJ, Wharton J; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH, Gräf S, Morrell NW.

Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017 Sep 28.

43.

Nature versus intensity of intoxication: Co-ingestion of alcohol and energy drinks and the effect on objective and subjective intoxication.

Forward J, Akhurst J, Bruno R, Leong X, VanderNiet A, Bromfield H, Erny J, Bellamy T, Peacock A.

Drug Alcohol Depend. 2017 Nov 1;180:292-303. doi: 10.1016/j.drugalcdep.2017.08.013. Epub 2017 Sep 7.

PMID:
28942033
44.

Tapered polysilicon core fibers for nonlinear photonics: erratum.

Suhailin FH, Shen L, Healy N, Xiao L, Jones M, Hawkins T, Ballato J, Gibson UJ, Peacock AC.

Opt Lett. 2017 Sep 15;42(18):3553. doi: 10.1364/OL.42.003553.

PMID:
28914899
45.

The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.

Price LC, Dimopoulos K, Marino P, Alonso-Gonzalez R, McCabe C, Kemnpy A, Swan L, Boutsikou M, Al Zahrani A, Coghlan GJ, Schreiber BE, Howard LS, Davies R, Toshner M, Pepke-Zaba J, Church AC, Peacock A, Corris PA, Lordan JL, Gaine S, Condliffe R, Kiely DG, Wort SJ.

Thorax. 2017 Nov;72(11):1035-1045. doi: 10.1136/thoraxjnl-2016-209725. Epub 2017 Sep 12. Review.

PMID:
28904006
46.

Perception of intoxication in a field study of the night-time economy: Blood alcohol concentration, patron characteristics, and event-level predictors.

Kaestle CE, Droste N, Peacock A, Bruno R, Miller P.

Addict Behav. 2018 Jan;76:195-200. doi: 10.1016/j.addbeh.2017.08.018. Epub 2017 Aug 18.

PMID:
28846940
47.

Polymyxin B containing polyion complex (PIC) nanoparticles: Improving the antimicrobial activity by tailoring the degree of polymerisation of the inert component.

Insua I, Zizmare L, Peacock AFA, Krachler AM, Fernandez-Trillo F.

Sci Rep. 2017 Aug 24;7(1):9396. doi: 10.1038/s41598-017-09667-3.

48.

Socialising Health Burden Through Different Network Topologies: A Simulation Study.

Peacock A, Cheung A, Kim P, Poon SK.

Stud Health Technol Inform. 2017;239:112-118.

PMID:
28756445
49.

A study of clinical and physiological relations of daily physical activity in precapillary pulmonary hypertension.

Panagiotou M, Johnson MK, Louvaris Z, Baker JS, Church AC, Peacock AJ, Vogiatzis I.

J Appl Physiol (1985). 2017 Oct 1;123(4):851-859. doi: 10.1152/japplphysiol.00986.2016. Epub 2017 Jun 29.

50.

Measuring the effects of treatment in patients with PAH: should we image the right ventricle?

Peacock AJ.

Eur Respir J. 2017 Jun 29;49(6). pii: 1700805. doi: 10.1183/13993003.00805-2017. Print 2017 Jun. No abstract available.

Supplemental Content

Loading ...
Support Center